GUARNIERI, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 68
AS - Asia 31
NA - Nord America 30
SA - Sud America 10
OC - Oceania 1
Totale 140
Nazione #
IT - Italia 49
US - Stati Uniti d'America 28
SG - Singapore 18
BR - Brasile 9
DE - Germania 8
CN - Cina 6
HK - Hong Kong 5
EE - Estonia 2
GB - Regno Unito 2
IN - India 2
MX - Messico 2
PL - Polonia 2
SE - Svezia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
FI - Finlandia 1
RU - Federazione Russa 1
Totale 140
Città #
Dallas 9
Singapore 9
Bari 8
Munich 8
Hefei 6
Hong Kong 5
Casavatore 3
New York 3
Santa Clara 3
Brooklyn 2
Catanzaro 2
Gioia Tauro 2
Mexico City 2
Naples 2
Rome 2
Rovereto 2
Warsaw 2
Acreúna 1
Chennai 1
Columbus 1
Floriano 1
Florissant 1
Franco da Rocha 1
Igarassu 1
Jaipur 1
Miami 1
Milan 1
Oklahoma City 1
Poplar 1
Praia Grande 1
Quixadá 1
Resistencia 1
Rostov-on-Don 1
Stockholm 1
Sydney 1
São José dos Campos 1
São Paulo 1
Taubaté 1
Turku 1
Vienna 1
Totale 93
Nome #
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 48
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 26
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 21
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 18
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective 17
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy 17
Totale 147
Categoria #
all - tutte 1.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 2 0 0 0 0 0 3
2024/2025100 3 0 1 26 5 4 29 1 7 3 4 17
2025/202642 15 25 2 0 0 0 0 0 0 0 0 0
Totale 147